Burcon NutraScience Statistics
Total Valuation
BRCNF has a market cap or net worth of 20.39 million. The enterprise value is 33.28 million.
| Market Cap | 20.39M |
| Enterprise Value | 33.28M |
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 12.69M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +44.08% |
| Shares Change (QoQ) | +27.72% |
| Owned by Insiders (%) | 15.45% |
| Owned by Institutions (%) | 0.10% |
| Float | 7.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 57.12 |
| PB Ratio | 7.73 |
| P/TBV Ratio | 11.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.60 |
| EV / Sales | 95.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.85 |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 6.19.
| Current Ratio | 1.23 |
| Quick Ratio | 1.08 |
| Debt / Equity | 6.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.36 |
| Interest Coverage | -6.66 |
Financial Efficiency
Return on equity (ROE) is -278.59% and return on invested capital (ROIC) is -29.28%.
| Return on Equity (ROE) | -278.59% |
| Return on Assets (ROA) | -28.01% |
| Return on Invested Capital (ROIC) | -29.28% |
| Return on Capital Employed (ROCE) | -37.29% |
| Revenue Per Employee | 23,804 |
| Profits Per Employee | -482,484 |
| Employee Count | 15 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 13.87 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.09% in the last 52 weeks. The beta is 2.75, so BRCNF's price volatility has been higher than the market average.
| Beta (5Y) | 2.75 |
| 52-Week Price Change | -26.09% |
| 50-Day Moving Average | 1.81 |
| 200-Day Moving Average | 1.62 |
| Relative Strength Index (RSI) | 49.42 |
| Average Volume (20 Days) | 2,337 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BRCNF had revenue of 357,054 and -7.24 million in losses. Loss per share was -0.79.
| Revenue | 357,054 |
| Gross Profit | -1.71M |
| Operating Income | -6.17M |
| Pretax Income | -7.24M |
| Net Income | -7.24M |
| EBITDA | -5.97M |
| EBIT | -6.17M |
| Loss Per Share | -0.79 |
Balance Sheet
The company has 3.10 million in cash and 16.33 million in debt, giving a net cash position of -13.23 million.
| Cash & Cash Equivalents | 3.10M |
| Total Debt | 16.33M |
| Net Cash | -13.23M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.64M |
| Book Value Per Share | 0.21 |
| Working Capital | 726,641 |
Cash Flow
In the last 12 months, operating cash flow was -4.65 million and capital expenditures -202,876, giving a free cash flow of -4.86 million.
| Operating Cash Flow | -4.65M |
| Capital Expenditures | -202,876 |
| Free Cash Flow | -4.86M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,727.37% |
| Pretax Margin | -2,026.94% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BRCNF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -44.08% |
| Shareholder Yield | -44.08% |
| Earnings Yield | -35.49% |
| FCF Yield | -23.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 11, 2025. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 11, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
BRCNF has an Altman Z-Score of -8.37 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.37 |
| Piotroski F-Score | 2 |